Shawn Dilkes - Nukkleus Chief Officer
| NUKK Stock | USD 1.79 0.13 7.83% |
Insider
Shawn Dilkes is Chief Officer of Nukkleus
| Address | 525 Washington Boulevard, Jersey City, NJ, United States, 07310 |
| Phone | 212-791-4663 |
| Web | https://www.nukk.com |
Nukkleus Management Efficiency
The company has return on total asset (ROA) of (1.1502) % which means that it has lost $1.1502 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.4205) %, meaning that it created substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.48. Return On Capital Employed is expected to rise to -1.12 this year. Total Current Liabilities is expected to rise to about 9 M this year. Liabilities And Stockholders Equity is expected to rise to about 22.2 M this yearSimilar Executives
| Showing other executives | INSIDER Age | ||
| Shinichi Fujikawa | BASE Inc | 50 | |
| Masaki Kawaguchi | BASE Inc | N/A | |
| John Bay | CurrentC Power | N/A | |
| Dietmar Haas | CurrentC Power | N/A | |
| Yuta Tsuruoka | BASE Inc | 24 | |
| Eric Bussy | Esker SA | 48 | |
| Kosuke Hotta | BASE Inc | N/A | |
| Kenji Yamamura | BASE Inc | N/A | |
| JeanMichel Berard | Esker SA | 61 | |
| Steve Smith | Esker SA | 61 | |
| Victor III | CurrentC Power | N/A | |
| Nao Takahashi | BASE Inc | N/A | |
| Claire Valencony | Esker SA | N/A | |
| Masahito Jinguji | BASE Inc | N/A | |
| Richard Perine | CurrentC Power | N/A | |
| JeanJacques Berard | Esker SA | 57 | |
| Ken Harada | BASE Inc | N/A | |
| Emmanuel Olivier | Esker SA | 55 | |
Management Performance
| Return On Equity | -7.42 | ||||
| Return On Asset | -1.15 |
Nukkleus Leadership Team
Elected by the shareholders, the Nukkleus' board of directors comprises two types of representatives: Nukkleus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nukkleus. The board's role is to monitor Nukkleus' management team and ensure that shareholders' interests are well served. Nukkleus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nukkleus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jamal Khurshid, COO Director | ||
| Emil Assentato, President CEO, Treasurer, Secretary, Director | ||
| Menachem Shalom, CEO Director | ||
| Andrew MBA, Chief Officer | ||
| Shawn Dilkes, Chief Officer |
Nukkleus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nukkleus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.42 | ||||
| Return On Asset | -1.15 | ||||
| Profit Margin | (2.53) % | ||||
| Operating Margin | (7.94) % | ||||
| Current Valuation | 6.35 M | ||||
| Shares Outstanding | 2.67 M | ||||
| Shares Owned By Insiders | 34.99 % | ||||
| Shares Owned By Institutions | 2.01 % | ||||
| Number Of Shares Shorted | 21.68 K | ||||
| Price To Earning | (40.00) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.36) | Revenue Per Share 7.024 | Quarterly Revenue Growth (0.97) | Return On Assets (1.15) | Return On Equity (7.42) |
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.